Hibergene Diagnostics, previously recognized as a rising star in Irish medtech for its Covid diagnostic kits, recently faced liquidation following tension with shareholders. Management accused discordant shareholders of undermining investor trust, culminating in those shareholders pursuing the appointment of their liquidator. Currently, liquidator Colin Gaynor is overseeing the liquidation process, with reports submitted to the Corporate Enforcement Authority. Extensive fees have accumulated during this timeline, reflecting the financial toll of the company's collapse and signaling ongoing asset recovery efforts.
"Hibergene was once billed as an up-and-coming star of Irish medtech, with its diagnostic kits gaining prominence during the Covid pandemic."
"Management blamed disgruntled shareholders for spooking potential investors, as a group of unhappy shareholders sought to have their own liquidator appointed."
Collection
[
|
...
]